MedPath

A clinical study on PALATTIRIKKATI CURANAM in the management of Atitulam (Obesity)

Phase 2
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2020/05/025001
Lead Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

BMI- More than 27 up to 35

WHR- More than 0.85 up to 1.00

Diagnosed Hypertension, Diabetes Mellitus

Exclusion Criteria

age below 20 and above 65

BMI - Below 27 & above 35

WHR - Below 0.85 & above 1.00

Renal Diseases

Endocrine diseases

Familial obesity

Pregnancy

Lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
weight and complains reduction during treatment or after treatmentTimepoint: weight and complains reduction during treatment or after treatment
Secondary Outcome Measures
NameTimeMethod
Find the pre clinical study of the trial drug. <br/ ><br> <br/ ><br>To find out the cost effectiveness of the trial drug <br/ ><br> <br/ ><br>To find out the prevalence of atitulam among the patients. <br/ ><br> <br/ ><br>Timepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath